Palliative Care Oncology in Patients With Relapsed, Refractory, and High-Risk Leukemias or High-Risk Myelodysplastic Syndrome: Randomized Phase II Study
More Information
- Trial Status
- Accepting patients
- Trial Phase
- Phase 2
- Enrollment
- 105 patients (estimated)
- Sponsors
- University of Virginia
- Tags
- Randomization
- Trial Type
- Supportive
- Last Update
- 2 months ago
- SparkCures ID
- 1549
- NCT Identifier
- NCT04482894
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print this trial to share with your doctor.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.